1105662-99-4 Usage
Uses
Used in Pharmaceutical Synthesis:
(3-amino-oxetan-3-yl)-acetic acid methyl ester is utilized as a building block in the synthesis of pharmaceuticals for its potential to contribute to the development of novel drug molecules. Its unique structure allows for versatile chemical modifications, facilitating the creation of new compounds with therapeutic potential.
Used in Drug Development:
In the realm of drug development, (3-amino-oxetan-3-yl)-acetic acid methyl ester is considered as a potential drug candidate itself. Its specific structural features may endow it with biological activities that could be harnessed for treating various medical conditions. Further research is essential to explore its pharmacological properties and validate its efficacy and safety.
Used in Medicinal Chemistry Research:
(3-amino-oxetan-3-yl)-acetic acid methyl ester serves as a valuable subject of study in medicinal chemistry research. Scientists are intrigued by its structural attributes and are investigating its interactions with biological targets, which could lead to a better understanding of its potential applications and mechanisms of action.
Note: Since the provided materials do not specify particular industries or detailed applications, the uses listed are general and based on the potential of the compound in the fields of medicinal chemistry and drug development. Further research would be required to identify specific applications and industries where (3-amino-oxetan-3-yl)-acetic acid methyl ester could be effectively utilized.
Check Digit Verification of cas no
The CAS Registry Mumber 1105662-99-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,5,6,6 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1105662-99:
(9*1)+(8*1)+(7*0)+(6*5)+(5*6)+(4*6)+(3*2)+(2*9)+(1*9)=134
134 % 10 = 4
So 1105662-99-4 is a valid CAS Registry Number.
1105662-99-4Relevant academic research and scientific papers
Furo-3-carboxamide derivatives and methods of use
-
Page/Page column 102; 104, (2017/10/24)
Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein R1, Z1, Z2, and n are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by Tropomysin receptor kinases (Trk). Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
FURO-3-CARBOXAMIDE DERIVATIVES AND METHODS OF USE
-
Paragraph 0621; 0631, (2015/08/04)
Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein R1, Z1, Z2, and n are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by Tropomysin receptor kinases (Trk). Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
HETEROCYCLIC COMPOUNDS USEFUL AS MK2 INHIBITORS
-
Page/Page column 51, (2009/03/07)
The present invention describes tetracyclic compounds of formula (IA) or (IB), wherein the symbols R, X, A, Y, R2, R3 and D are as defined in the specification, their use in the treatment of certain diseases, e.g. depending on MK-2 or TNF activity, and wa
